• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NXS
Click for more information
13.3% 47.0¢

NEXT SCIENCE LIMITED

Market Cap $137.0M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Medical Instruments & Supplies

Next Science Limited is an Australia-based medical technology company. The Company’s... Next Science Limited is an Australia-based medical technology company. The Company’s primary focus is on the development and commercialization of its proprietary XBIO technology to reduce the impact of biofilm-based infections on human health. XBIO is a non-toxic technology with an efficacy in eradicating both biofilm-based and free-floating bacteria. The Company’s products include XPERIENCE, Blast X, SurgX and Bactisure. The XPERIENCE product is an antimicrobial solution used to prevent surgical site infections by rinsing away debris and microorganisms. SurgX Sterile Antimicrobial Gel is used to reduce surgical site and post-surgical infections by destroying planktonic and biofilm-based bacteria within the gel with sustained effectiveness for up to five days. BLASTX Antimicrobial Wound Gel provides wound management by maintaining a moist wound environment, which is conducive to wound healing.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
NXS
Ann: Preliminary results of further XPERIENCE studies released 		18/04/24 6 1.2K
18/04/24 Last post  Crocaman Comments Created with Sketch.  6  Views Created with Sketch.  1.2K 
NXS
technical analysis chart 		18/04/24 4 746
18/04/24 Last post  cheesepope Comments Created with Sketch.  4  Views Created with Sketch.  746 
NXS
Ann: Publication of Dr. Harris XPERIENCE study 		18/04/24 5 788
18/04/24 Last post  EllieC Comments Created with Sketch.  5  Views Created with Sketch.  788 
NXS
Bell Potter fined in 2017 for price manipulation 		16/04/24 35 12K
16/04/24 Last post  Montytheman Comments Created with Sketch.  35  Views Created with Sketch.  12K 
NXS
Ann: Study published showing impact of XPERIENCE on SSIs 		16/04/24 0 246
16/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  246 
NXS
Ann: FY23 Annual Result Investor Presentation 		15/04/24 9 2.5K
15/04/24 Last post  jaluma Comments Created with Sketch.  9  Views Created with Sketch.  2.5K 
NXS
Ann: Publication of study showing BLASTX increases NPWT efficacy 		09/04/24 0 262
09/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  262 
NXS
Ann: 2023 Annual Report 		08/04/24 8 2.2K
08/04/24 Last post  EDDYDudes Comments Created with Sketch.  8  Views Created with Sketch.  2.2K 

See All Discussions arrow Created with Sketch.

Timeline

Publication of Dr. Harris XPERIENCE study
18 Apr 09:39
 
Preliminary results of further XPERIENCE studies released
17 Apr 08:27
 
Study published showing impact of XPERIENCE on SSIs
16 Apr 09:02
 
Publication of study showing BLASTX increases NPWT efficacy
09 Apr 09:33
 
Appendix 4G & 2024 Corporate Governance Statement
05 Apr 12:10
 
2023 Annual Report
05 Apr 12:08
 
View More arrow Created with Sketch.

Featured News

NEWS Chris Judd's Talk Ya Book: Furnishing a short position on TPW
right-arrow Created with Sketch.
NEWS Week 15 Wrap: USA uncertain, ECB shrugs at the Fed & gold, gold, gold
right-arrow Created with Sketch.
RCE Recce Pharmaceuticals up on new antibiotic production milestone
right-arrow Created with Sketch.
FHE Frontier Energy closes in on $225m debt financing for Waroona Renewable Energy Project
right-arrow Created with Sketch.
BGD Barton share purchase plan strikes a chord for SA gold projects
right-arrow Created with Sketch.
TLX Telix Pharmaceuticals granted US-FDA fast track designation for brain cancer detection
right-arrow Created with Sketch.
(20min delay)
Last
47.0¢ 		Change
0.055(13.3%) 		Mkt cap ! $137.0M
Open High Low Value Volume
42.0¢ 50.0¢ 41.0¢ $222.6K 496.0K

Buyers (Bids)

No. Vol. Price($)
1 2926 46.5¢
 

Sellers (Offers)

Price($) Vol. No.
47.0¢ 8530 1
View Market Depth
Last trade - 16.10pm 18/04/2024 (20 minute delay) ?
Last
49.0¢ 		  Change
0.055 ( 16.7 %)
Open High Low Volume
41.0¢ 50.0¢ 41.0¢ 16901
Last updated 15.43pm 18/04/2024 ?
NXS (ASX) Chart

Top Stories

Chariots of fire on pole to meet resurgent US lithium security focus.

Chariot Corporation is a company in a hurry.Since listing on the Australian stock exchange (ASX) in October, Chariot’s focus has been on building up a significant suite of lithium projects across three US states with the goal of securing future supply of the mineral to fulfil a vo...
Market Update: Energy keeps light bright in a sea of red The ASX is down .7 of a per cent with every sector - except energy - in the red and real estate diving nearly 2 per cent mid-session.
Canada's Hillcrest Energy (CSE.HEAT) partners with BC's Powertech Labs Canada-based Hillcrest Energy Technologies has teamed up with British Columbia-based Powertech Labs to test Hillcrest's ZVS technology.
Recce Pharmaceuticals up 6% on new antibiotic production milestone Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Week 15 Wrap: USA uncertain, ECB shrugs at the Fed & gold, gold, gold Depending on what interests you more, there were two big stories this week for the international finance space.

Featured News

LGP Little Green Pharma heading into Q2 cashed up after record sales
right-arrow Created with Sketch.
RCE Recce Pharmaceuticals up on new antibiotic production milestone
right-arrow Created with Sketch.
FHE Frontier Energy closes in on $225m debt financing for Waroona Renewable Energy Project
right-arrow Created with Sketch.
NEWS Frontier Energy nears $225M financing milestone: Click here to join discussion
right-arrow Created with Sketch.
BGD Barton share purchase plan strikes a chord for SA gold projects
right-arrow Created with Sketch.
RDN Raiden rolls up heritage work at twin Pilbara lithium plays
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.